A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-16
DOI
10.1038/s41467-019-09917-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
- (2017) Veronica Tisato et al. Journal of Hematology & Oncology
- AMKL chimeric transcription factors are potent inducers of leukemia
- (2017) J Dang et al. LEUKEMIA
- Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
- (2017) Jasmijn D E de Rooij et al. NATURE GENETICS
- Evaluation of artemisinins for the treatment of acute myeloid leukemia
- (2016) Christina D. Drenberg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
- (2016) Joseph Ciccolini et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression
- (2016) CD Drenberg et al. CTS-Clinical and Translational Science
- Acute myeloid leukemia patients clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts
- (2016) B. Reis et al. HAEMATOLOGICA
- The role of the proteasome in AML
- (2016) C M Csizmar et al. Blood Cancer Journal
- Acute myeloid leukemia patients clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts
- (2016) B. Reis et al. HAEMATOLOGICA
- The biology of pediatric acute megakaryoblastic leukemia
- (2015) T. A. Gruber et al. BLOOD
- Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the Pediatric Preclinical Testing Program
- (2015) C. Patrick Reynolds et al. PEDIATRIC BLOOD & CANCER
- A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
- (2015) Mignon L. Loh et al. PEDIATRIC BLOOD & CANCER
- The Emerging Role of Gemcitabine in Conditioning Regimens for Hematopoietic Stem Cell Transplantation
- (2014) Emily Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation
- (2014) R. Besancenot et al. BLOOD
- Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
- (2014) H. Dohner et al. BLOOD
- Advances in treatment of de-novo pediatric acute myeloid leukemia
- (2014) Raul C. Ribeiro CURRENT OPINION IN ONCOLOGY
- Mechanistic interpretation of conventional Michaelis–Menten parameters in a transporter system
- (2014) Diana Vivian et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC–MS/MS: Application to a pharmacokinetic study
- (2014) Sridhar Veeraraghavan et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
- (2014) B T Gjertsen et al. LEUKEMIA
- Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine
- (2014) Auke D Adema et al. SpringerPlus
- Eradicating acute myeloid leukemia in a MllPTD/wt:Flt3ITD/wt murine model: a path to novel therapeutic approaches for human disease
- (2013) K. M. Bernot et al. BLOOD
- High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
- (2013) V Grossmann et al. LEUKEMIA
- Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
- (2013) Lars Petter Jordheim et al. NATURE REVIEWS DRUG DISCOVERY
- Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
- (2013) Chengzhi Xie et al. PLoS One
- Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias
- (2012) N. A. Zorko et al. BLOOD
- Childhood acute myeloid leukaemia
- (2012) Jeffrey E. Rubnitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
- (2012) Tanja A. Gruber et al. CANCER CELL
- Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
- (2012) Qiang Wen et al. CELL
- Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation
- (2012) Y Chen et al. LEUKEMIA
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Regeneration of Three Layers Vascular Wall by using BMP2-Treated MSC Involving HIF-1α and Id1 Expressions Through JAK/STAT Pathways
- (2011) Karim Belmokhtar et al. Stem Cell Reviews and Reports
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Nucleoside analogs: molecular mechanisms signaling cell death
- (2008) B Ewald et al. ONCOGENE
- SLC28 genes and concentrative nucleoside transporter (CNT) proteins
- (2008) M. Pastor-Anglada et al. XENOBIOTICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search